Evaluation of Fractional Exhaled Nitric Oxide During SARS-CoV-2 Infection.

Abstract

J Investig Allergol Clin Immunol 2022; Vol. 32(4): 299-303 © 2022 Esmon Publicidad 4. Baiardini I, Paoletti G, Malipiero G, Giua C, Keber E, Canonica GW, et al. Validation of the Italian Version of the Test of Adherence to Inhalers. J Investig Allergol Clin Immunol. 2020;30(6):450-2. 5. Ortega-Martin L, Betancor D, Barroso B, Valverde-Monge M, Santillan J, Villacampa JM, et al. Where Has All The Nasal Polyposis Gone? J Investig Allergol Clin Immunol. 2021;31:500-2. 6. Rudmik L, Xu Y, Liu M, Bird C, Kukec E, Quan H. Utilization Patterns of Topical Intranasal Steroid Therapy for Chronic Rhinosinusitis: A Canadian Population-Based Analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(11):1056-62. 7. Philpott C, Erskine S, Smith R, Hopkins C, Kara N, Farboud A, et al. Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study (CRES). Clin Otolaryngol. 2018;43(2):50924. 8. Phillips KM, Hoehle LP, Caradonna DS, Gray ST, Sedaghat AR. Intranasal corticosteroids and saline: Usage and adherence in chronic rhinosinusitis patients. Laryngoscope. 2020;130(4):852-6. 9. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006;118(5 Suppl):S17-61. Evaluation of Fractional Exhaled Nitric Oxide During SARS-CoV-2 Infection